Literature DB >> 10941915

Synthesis and degradation characteristics of salicylic acid-derived poly(anhydride-esters).

L Erdmann1, K E Uhrich.   

Abstract

A biodegradable poly(anhydride-ester) was synthesized by melt condensation polymerization of the acetylated monomer to yield a novel polymeric prodrug. The polymer we have synthesized is composed of alkyl chains linked by ester bonds to aromatic moieties, specifically salicylic acid--the active component of aspirin. With the medicinal properties attributed to salicylic acid and the ease of metabolism, the incorporation of this compound into a polymer backbone yields a polymeric prodrug that may have potential in a variety of applications (i.e., inflammatory bowel disease). For these reasons, we have designed a synthetic scheme that yields the desired poly(anhydride-ester). The in vitro hydrolytic degradation of these polymers has been performed and results indicate that the polymer degradation rate is pH-dependent.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10941915     DOI: 10.1016/s0142-9612(00)00073-9

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  34 in total

1.  Phenolic Acid-based Poly(anhydride-esters) as Antioxidant Biomaterials.

Authors:  Almudena Prudencio; Jonathan J Faig; MinJung Song; Kathryn E Uhrich
Journal:  Macromol Biosci       Date:  2015-10-01       Impact factor: 4.979

Review 2.  Synthetic Biomaterials from Metabolically Derived Synthons.

Authors:  Nicole G Ricapito; Cynthia Ghobril; Heng Zhang; Mark W Grinstaff; David Putnam
Journal:  Chem Rev       Date:  2016-01-29       Impact factor: 60.622

3.  Biodegradable coumaric acid-based poly(anhydride-ester) synthesis and subsequent controlled release.

Authors:  Michelle A Ouimet; Nicholas D Stebbins; Kathryn E Uhrich
Journal:  Macromol Rapid Commun       Date:  2013-07-09       Impact factor: 5.734

4.  Biodegradable polyanhydride-based nanomedicines for blood to brain drug delivery.

Authors:  Timothy M Brenza; Benjamin W Schlichtmann; Biju Bhargavan; Julia E Vela Ramirez; Rainie D Nelson; Matthew G Panthani; JoEllyn M McMillan; Balaraman Kalyanaraman; Howard E Gendelman; Vellareddy Anantharam; Anumantha G Kanthasamy; Surya K Mallapragada; Balaji Narasimhan; Georgette D Kanmogne
Journal:  J Biomed Mater Res A       Date:  2018-10-26       Impact factor: 4.396

5.  PolyMorphine: an innovative biodegradable polymer drug for extended pain relief.

Authors:  Roselin Rosario-Meléndez; Carolyn L Harris; Roberto Delgado-Rivera; Lei Yu; Kathryn E Uhrich
Journal:  J Control Release       Date:  2012-08-03       Impact factor: 9.776

6.  Biodegradable ferulic acid-containing poly(anhydride-ester): degradation products with controlled release and sustained antioxidant activity.

Authors:  Michelle A Ouimet; Jeremy Griffin; Ashley L Carbone-Howell; Wen-Hsuan Wu; Nicholas D Stebbins; Rong Di; Kathryn E Uhrich
Journal:  Biomacromolecules       Date:  2013-02-04       Impact factor: 6.988

7.  Intraperitoneal delivery of paclitaxel by poly(ether-anhydride) microspheres effectively suppresses tumor growth in a murine metastatic ovarian cancer model.

Authors:  Ming Yang; Tao Yu; Joseph Wood; Ying-Ying Wang; Benjamin C Tang; Qi Zeng; Brian W Simons; Jie Fu; Chi-Mu Chuang; Samuel K Lai; T-C Wu; Chien-Fu Hung; Justin Hanes
Journal:  Drug Deliv Transl Res       Date:  2014-04-01       Impact factor: 4.617

8.  Hydrolytic Degradation and Erosion of Polyester Biomaterials.

Authors:  Lindsay N Woodard; Melissa A Grunlan
Journal:  ACS Macro Lett       Date:  2018-07-30       Impact factor: 6.903

9.  Formulation of salicylate-based poly(anhydride-ester) microspheres for short- and long-term salicylic acid delivery.

Authors:  Roselin Rosario-Meléndez; Michelle A Ouimet; Kathryn E Uhrich
Journal:  Polym Bull (Berl)       Date:  2012-09-07       Impact factor: 2.870

10.  Concurrent release of admixed antimicrobials and salicylic acid from salicylate-based poly(anhydride-esters).

Authors:  Michelle L Johnson; Kathryn E Uhrich
Journal:  J Biomed Mater Res A       Date:  2009-12       Impact factor: 4.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.